# Phase 4 overweight trials recruiting: 33 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 33 trials in phase 4 for overweight that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 overweight trials: 33 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/overweight

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 33
- Recruiting or not yet: 33
- Read on: November 19, 2026

## Trials

The 25 newest of 33, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 14, 2026 | NCT07872904 | FutureShape Family | Sponsor not shown (see the record) | Phase 4 | Recruiting | Obesity, Overweight | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872904) |
| October 13, 2026 | NCT07870538 | A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge... | Universitaire Ziekenhuizen KU Leuven | Phase 4 | Recruiting | Obesity & Overweight | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07870538) |
| October 1, 2026 | NCT07850960 | Effect of Omeprazole on Gut Microbiota in Adults With Obesity and GERD | Federal State Budgetary Scientific Institution | Phase 4 | Not yet recruiting | Obesity & Overweight, Gastroesophageal Reflux Disease | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850960) |
| September 30, 2026 | NCT07850466 | TRPTI Metabolic and GLP-1 Pharmacodynamic Study | RDC Clinical Pty Ltd | Phase 4 | Not yet recruiting | Overweight , Obesity | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850466) |
| September 21, 2026 | NCT07832084 | Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Obesity & Overweight, Cardiometabolic Health Indicators | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832084) |
| August 25, 2026 | NCT07783854 | A Randomized Controlled Study of Dose-tapering Regimen of Semaglutide for Weight-Loss Maintenance in Adults With Overweight or Obesity | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 4 | Not yet recruiting | Obesity & Overweight | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783854) |
| August 10, 2026 | NCT07755085 | GLP-1s in Hip and Knee Arthroplasty | Nova Scotia Health Authority | Phase 4 | Not yet recruiting | Arthritis, Obesity & Overweight, GLP - 1 | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755085) |
| July 27, 2026 | NCT07728383 | A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity | Gila Therapeutics, Inc. | Phase 4 | Recruiting | Obesity & Overweight | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728383) |
| July 21, 2026 | NCT07715929 | Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Atrial Fibrillation, Obesity & Overweight, Catheter Ablation | 710 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715929) |
| July 13, 2026 | NCT07699445 | The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression | Massachusetts General Hospital | Phase 4 | Recruiting | Bipolar Depression Depressed Phase, Obesity & Overweight | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07699445) |
| June 18, 2026 | NCT07657676 | Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity | China National Center for Cardiovascular Diseases | Phase 4 | Recruiting | Obesity & Overweight, Coronary Heart Disease | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07657676) |
| June 12, 2026 | NCT07646158 | Alignment Techniques in TKA RCT | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Osteo Arthritis of the Knee, Obesity & Overweight | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646158) |
| May 18, 2026 | NCT07592546 | Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss | Sponsor not shown (see the record) | Phase 4 | Recruiting | Class I/II Obesity | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592546) |
| May 14, 2026 | NCT07588438 | Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. | Las Rías Medical Center | Phase 4 | Recruiting | Obesity, Diabetes Mellitus, Type 2 | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588438) |
| April 29, 2026 | NCT07555730 | AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN) | Huazhong University of Science and Technology | Phase 4 | Not yet recruiting | Overweight or Obesity; Type 2 Diabetes, Weight Loss Maintenance | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07555730) |
| April 28, 2026 | NCT07554417 | Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates... | William Marsh Rice University | Phase 4 | Not yet recruiting | GLP - 1, Obesity & Overweight, Muscle Loss, Exercise Intervention, Dietary Assessment | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554417) |
| March 20, 2026 | NCT07485764 | Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 4 | Not yet recruiting | Psoriasis, Plaque Psoriasis, Moderate-to-severe Plaque Psoriasis, Overweight , Obesity | 186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07485764) |
| March 10, 2026 | NCT07462663 | SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage... | Hospital Universitari de Bellvitge | Phase 4 | Not yet recruiting | Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07462663) |
| February 11, 2026 | NCT07401992 | Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis | Hospital Universitario Dr. Jose E. Gonzalez | Phase 4 | Recruiting | Psoriasis (PsO), Obesity & Overweight, Diabetes Mellitus - Type 2 | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07401992) |
| January 21, 2026 | NCT07354880 | Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease | University Medical Centre Ljubljana | Phase 4 | Not yet recruiting | Obesity & Overweight, Adult Congenital Heart Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354880) |
| January 8, 2026 | NCT07326111 | A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese | University of Bonn | Phase 4 | Recruiting | Polycystic Ovary Syndrome (PCOS), Obesity & Overweight | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07326111) |
| December 31, 2025 | NCT07311551 | A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus... | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Type 2 Diabetes | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07311551) |
| December 24, 2025 | NCT07301437 | RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients. | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Phase 4 | Not yet recruiting | Overweight and Obese Adults | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07301437) |
| December 10, 2025 | NCT07275697 | Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study | Sponsor not shown (see the record) | Phase 4 | Recruiting | Atrial Fibrillation (AF), Obesity & Overweight | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07275697) |
| November 25, 2025 | NCT07247084 | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK) | Eli Lilly and Company | Phase 4 | Recruiting | Obesity | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247084) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 2 |
| University Medical Centre Ljubljana | 1 |
| Massachusetts General Hospital | 1 |
| Federal State Budgetary Scientific Institution | 1 |
| Hospital Universitario Dr. Jose E. Gonzalez | 1 |
| Las Rías Medical Center | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| William Marsh Rice University | 1 |
| Huazhong University of Science and Technology | 1 |
| University Hospital, Tours | 1 |
| Gila Therapeutics, Inc. | 1 |
| [RDC Clinical Pty Ltd](https://specstream.ai/data/clinical-trials/company/rdc-clinical-pty-ltd) | 1 |
| Nova Scotia Health Authority | 1 |
| Fundacion Dexeus | 1 |
| Hospital Universitari de Bellvitge | 1 |
| Turku University Hospital | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
| University of Bonn | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 5 |
| China | 5 |
| Denmark | 2 |
| Canada | 2 |
| Sweden | 1 |
| Austria | 1 |
| Russia | 1 |
| Mexico | 1 |
| Paraguay | 1 |
| France | 1 |
| Australia | 1 |
| Spain | 1 |
| Finland | 1 |
| Belgium | 1 |
| Germany | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Business schools in the United States](https://specstream.ai/data/businesses/business-schools/united-states)
- [Fingerprinting services in the United States](https://specstream.ai/data/businesses/fingerprinting-services/united-states)
- [Mattress manufacturing companies in the United States](https://specstream.ai/data/businesses/mattress-manufacturing-companies/united-states)
- [Road contractors in the United States](https://specstream.ai/data/businesses/road-contractors/united-states)
- [Advertising agencies in the United States](https://specstream.ai/data/businesses/advertising-agencies/united-states)
- [Closet remodeling companies in the United States](https://specstream.ai/data/businesses/closet-remodeling-companies/united-states)
